Page last updated: 2024-10-30

lorazepam and Intellectual Disability

lorazepam has been researched along with Intellectual Disability in 7 studies

Lorazepam: A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent.

Intellectual Disability: Subnormal intellectual functioning which originates during the developmental period. This has multiple potential etiologies, including genetic defects and perinatal insults. Intelligence quotient (IQ) scores are commonly used to determine whether an individual has an intellectual disability. IQ scores between 70 and 79 are in the borderline range. Scores below 67 are in the disabled range. (from Joynt, Clinical Neurology, 1992, Ch55, p28)

Research Excerpts

ExcerptRelevanceReference
"Acute catatonia of the retarded type responds rapidly to treatment with lorazepam."7.69Lorazepam treatment of acute and chronic catatonia in two mentally retarded brothers. ( Gaind, GS; Mazurek, MF; Rosebush, PI, 1994)
"Acute catatonia of the retarded type responds rapidly to treatment with lorazepam."3.69Lorazepam treatment of acute and chronic catatonia in two mentally retarded brothers. ( Gaind, GS; Mazurek, MF; Rosebush, PI, 1994)
" The degree of hyperactivity was not systematically related to dosage level."2.64Effects of lorazepam on hyperactivity in ratarded children. ( Beale, IL; Singh, N; Walters, A, 1977)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19901 (14.29)18.7374
1990's2 (28.57)18.2507
2000's1 (14.29)29.6817
2010's3 (42.86)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Garel, N1
Joober, R1
Wahidi, N1
de Leon, J1
Swart, GT1
Siman, E1
Stewart, SL1
Hammerman, S1
Lam, C1
Caroff, SN1
Gross, EJ1
Hull, HG1
Lytton, GJ1
Hill, JA1
Piersel, WC1
Gaind, GS1
Rosebush, PI1
Mazurek, MF1
Walters, A1
Singh, N1
Beale, IL1

Trials

1 trial available for lorazepam and Intellectual Disability

ArticleYear
Effects of lorazepam on hyperactivity in ratarded children.
    The New Zealand medical journal, 1977, Nov-23, Volume: 86, Issue:600

    Topics: Adolescent; Anti-Anxiety Agents; Child; Child, Preschool; Clinical Trials as Topic; Double-Blind Met

1977

Other Studies

6 other studies available for lorazepam and Intellectual Disability

ArticleYear
Treatment of first-episode psychosis in patients with autism-spectrum disorder and intellectual deficiency
    Journal of psychiatry & neuroscience : JPN, 2019, Nov-01, Volume: 44, Issue:6

    Topics: Adolescent; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Autism Spectrum Disorder; D

2019
Rapid Development of Lorazepam Tolerance Within 48 Hours in an Adult With Intellectual Disability Who Presented With Stuporous Catatonia and Refused Electroconvulsive Therapy.
    The primary care companion for CNS disorders, 2018, May-17, Volume: 20, Issue:3

    Topics: Benzodiazepines; Catatonia; Drug Tolerance; Humans; Intellectual Disability; Lorazepam; Male; Middle

2018
The use of Pro Re Nata or Statim medications for behavioral control: a summary of experience at a tertiary care children's mental health center.
    Journal of child and adolescent psychopharmacology, 2011, Volume: 21, Issue:1

    Topics: Adolescent; Age Factors; Aggression; Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Chi

2011
Neuroleptic malignant syndrome and aripiprazole.
    Journal of the American Academy of Child and Adolescent Psychiatry, 2006, Volume: 45, Issue:6

    Topics: Adolescent; Anti-Anxiety Agents; Antipsychotic Agents; Aripiprazole; Depressive Disorder; Female; Hu

2006
Case study of neuroleptic-induced akathisia: important implications for individuals with mental retardation.
    American journal of mental retardation : AJMR, 1993, Volume: 98, Issue:1

    Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Chlorpromazine; Clorazepate Dipotassium; Diagn

1993
Lorazepam treatment of acute and chronic catatonia in two mentally retarded brothers.
    The Journal of clinical psychiatry, 1994, Volume: 55, Issue:1

    Topics: Adult; Catatonia; Chronic Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; F

1994